SCHEMBL7157672

SCHEMBL7157672

O[C@H]([CH]Cc1ccccc1)CNCCc1ccccn1

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.56
ALDH1A1 P00352 2/20 0.56
CYP2C19 P33261 1/20 0.56
HRH3 Q9Y5N1 1/20 0.44
KDM4E B2RXH2 2/20 0.44
ALOX15 P16050 2/20 0.43
LMNA P02545 2/20 0.43
TAAR1 Q96RJ0 1/20 0.43
DPP7 Q9UHL4 1/20 0.42
KMT2A Q03164 1/20 0.42
TDP1 Q9NUW8 2/20 0.42
CYP2D6 P10635 1/20 0.42
HPGD P15428 1/20 0.42
CYP3A4 P08684 1/20 0.42
HTT P42858 1/20 0.40
ATM Q13315 1/20 0.40
ADRB2 P07550 1/20 0.40
ADRB1 P08588 1/20 0.40
ADRA1D P25100 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4045617 0.77 ADRB1 (0.36) CYP1A2KDM4ELMNAKMT2ACYP2D6
SCHEMBL4036513 0.77 RPS6KB1 (0.40) CYP1A2ALDH1A1KDM4ELMNAKMT2A
SCHEMBL5391447 0.76 ABCB1 (0.46) CYP1A2LMNAKMT2ACYP2D6CYP3A4
SCHEMBL15318323 0.76 CYP1A2 (0.77) CYP1A2ALDH1A1CYP2C19HRH3KDM4E
SCHEMBL6894985 0.75 CYP1A2 (0.55) CYP1A2ALDH1A1CYP2C19HRH3KDM4E
SCHEMBL3348729 0.75 CYP1A2 (0.55) CYP1A2ALDH1A1CYP2C19HRH3KDM4E
SCHEMBL5707323 0.75 CYP1A2 (0.60) CYP1A2ALDH1A1CYP2C19HRH3KDM4E
SCHEMBL4045258 0.74 NR3C2 (0.41) KDM4EADRB2ADRB1
SCHEMBL6742452 0.74 CYP1A2 (0.60) CYP1A2ALDH1A1CYP2C19HRH3KDM4E
SCHEMBL5219600 0.74 ANPEP (0.46) CYP1A2ALDH1A1LMNAKMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2004502669-A 2004-01-29 JP claimed
EP-1353898-A2 COMPOUNDS TO TREAT ALZHEIMER'S DISEASE Elan Pharmaceuticals, Inc. (US) 2003-10-22 EP claimed
WO-2002002512-A2 COMPOUNDS TO TREAT ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. (US) 2002-01-10 WO claimed